ST

Srinivas Thejas

Active Director Designated Partner DIN 11476828
DIN 11476828 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivas Thejas

Data last updated:

Srinivas Thejas is a Designated Partner at Trio Cure Integrated Ayush Hospitals Llp (since 2026).

DIN 11476828
Primary Designation Designated Partner
First Appointment 10 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Jan 20262026Active

Board colleagues of Srinivas Thejas

NameDINCompanyDesignation
Divya Hari11476827Trio Cure Integrated Ayush Hospitals LlpDesignated Partner
Pavankumar Ramesh08245754Trio Cure Integrated Ayush Hospitals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Trio Cure Integrated Ayush Hospitals Llp
Premium access

Shareholding and investment profile for Srinivas Thejas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Thejas

Srinivas Thejas currently holds 1 directorship: Trio Cure Integrated Ayush Hospitals Llp (Designated Partner, since 10 Jan 2026).

Srinivas Thejas was first appointed on 10 Jan 2026 as Designated Partner at Trio Cure Integrated Ayush Hospitals Llp.

The current boards of Srinivas Thejas's companies include Divya Hari (Trio Cure Integrated Ayush Hospitals Llp), Pavankumar Ramesh (Trio Cure Integrated Ayush Hospitals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available